Author:
Hünseler C,Kribs A,Eifinger F,Roth B
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Pediatrics, Perinatology and Child Health
Reference19 articles.
1. Heuer L, Blumenberg D . Recombinant factor VIIa (NovoSeven®). A review of current and possible future indications. Anaesthesist 2002; 51: 388–399.
2. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN et al. Recombinant activated factor VII for acute intracerebral hemorrhage. New Engl J Med 2005; 352: 777–785.
3. Chuansumrit A, Visanuyothin N, Puapunwattana S, Chaivisuth A, Rasmidat P, Charoenkwan P et al. Outcome of intracranial hemorrhage in infants with congenital factor VII deficiency. J Med Assoc Thai 2002; 85(S4): 1059–1064.
4. Wong WY, Huang WC, Miller R, McGinty K, Whisnat JK . Clinical efficacy and recovery levels of recombinant FVIIa (Novoseven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency. Haemophilia 2000; 6: 50–54.
5. Tancabelic J, Haun SE . Management of coagulopathy with recombinant factor VIIa in a neonate with echovirus type 7. Pediatr Blood Cancer 2004; 43: 170–176.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献